Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3464)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$552.92
Total Value
$154.82K
Shares Held After
19,276
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$550.81
Total Value
$110.16K
Shares Held After
19,556
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,015
Price
$550.20
Total Value
$558.45K
Shares Held After
19,756
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,185
Price
$549.30
Total Value
$650.92K
Shares Held After
20,771
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,606
Price
$548.26
Total Value
$880.51K
Shares Held After
21,956
% of Holdings
6.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,354
Price
$547.11
Total Value
$740.79K
Shares Held After
23,562
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,520
Price
$546.23
Total Value
$1.38M
Shares Held After
24,916
% of Holdings
9.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,440
Price
$544.96
Total Value
$784.74K
Shares Held After
27,436
% of Holdings
5.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
5,000
Price
$3.83
Total Value
$19.15K
Shares Held After
1,064,029
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$3.87
Total Value
$58.05K
Shares Held After
1,184,327
% of Holdings
1.3%
Syndax Pharmaceuticals Inc (SNDX)
Goldan Keith A. — Chief Financial Officer
Shares
1,177
Price
$18.99
Total Value
$22.35K
Shares Held After
139,252
% of Holdings
0.8%
Syndax Pharmaceuticals Inc (SNDX)
Metzger Michael A — Director
Shares
6,847
Price
$18.99
Total Value
$130.02K
Shares Held After
484,843
% of Holdings
1.4%
MAIA Biotechnology, Inc. (MAIA)
Smith Stan — Director
Shares
75,000
Price
$1.34
Total Value
$100.20K
Shares Held After
1,519,178
% of Holdings
4.9%
MAIA Biotechnology, Inc. (MAIA)
Vitoc Vlad — Director
Shares
72,700
Price
$1.39
Total Value
$100.89K
Shares Held After
976,121
% of Holdings
7.4%
MAIA Biotechnology, Inc. (MAIA)
Gryaznov Sergei — Chief Scientific Officer
Shares
2,000
Price
$1.34
Total Value
$2.69K
Shares Held After
46,511
% of Holdings
4.3%
MediWound Ltd. (MDWD)
Fox David Morton — Director
Shares
1,797
Price
$13.99
Total Value
$25.15K
Shares Held After
22,283
% of Holdings
8.1%
MediWound Ltd. (MDWD)
Fox David Morton — Director
Shares
10
Price
$14.23
Total Value
$142.30
Shares Held After
20,486
% of Holdings
0.0%
MediWound Ltd. (MDWD)
Fox David Morton — Director
Shares
1,730
Price
$14.22
Total Value
$24.61K
Shares Held After
20,476
% of Holdings
8.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Soergel David — Chief Medical Officer
Shares
1,042
Price
$495.74
Total Value
$516.56K
Shares Held After
10,033
% of Holdings
9.4%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$41.67
Total Value
$375.04K
Shares Held After
77,389
% of Holdings
10.4%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,653
Price
$23.77
Total Value
$110.60K
Shares Held After
105,689
% of Holdings
4.2%
Arcus Biosciences, Inc. (RCUS)
Azoy Alexander — Chief Accounting Officer
Shares
2,562
Price
$25.77
Total Value
$66.02K
Shares Held After
39,581
% of Holdings
6.1%
CYTOKINETICS INC (CYTK)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$74.08
Total Value
$370.40K
Shares Held After
15,784
% of Holdings
24.1%
CYTOKINETICS INC (CYTK)
Kaye Edward M. MD — Director
Shares
2,933
Price
$76.09
Total Value
$223.17K
Shares Held After
10,283
% of Holdings
22.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$74.08
Total Value
$1.11M
Shares Held After
58,555
% of Holdings
20.4%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
4,170
Price
$13.16
Total Value
$54.86K
Shares Held After
139,372
% of Holdings
2.9%
Sensei Biotherapeutics, Inc. (SNSE)
Peyer James — 10% Owner
Shares
476
Price
$21.14
Total Value
$10.06K
Shares Held After
130,142
% of Holdings
0.4%
Sensei Biotherapeutics, Inc. (SNSE)
Peyer James — 10% Owner
Shares
24,524
Price
$20.00
Total Value
$490.48K
Shares Held After
130,618
% of Holdings
15.8%
Sensei Biotherapeutics, Inc. (SNSE)
Cambrian BioPharma Inc — 10% Owner
Shares
476
Price
$21.14
Total Value
$10.06K
Shares Held After
130,142
% of Holdings
0.4%
Sensei Biotherapeutics, Inc. (SNSE)
Cambrian BioPharma Inc — 10% Owner
Shares
24,524
Price
$20.00
Total Value
$490.48K
Shares Held After
130,618
% of Holdings
15.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
262,682
Price
$15.31
Total Value
$4.02M
Shares Held After
12,494,481
% of Holdings
2.1%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
2,299
Price
$15.35
Total Value
$35.29K
Shares Held After
12,231,799
% of Holdings
0.0%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
303
Price
$5.01
Total Value
$1.52K
Shares Held After
181,858
% of Holdings
0.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,974
Price
$450.00
Total Value
$888.30K
Shares Held After
22,760
% of Holdings
8.0%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
6,000
Price
$233.46
Total Value
$1.40M
Shares Held After
41,140
% of Holdings
12.7%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$26.34
Total Value
$197.55K
Shares Held After
24,808
% of Holdings
23.2%
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
265
Price
$4.43
Total Value
$1.17K
Shares Held After
66,583
% of Holdings
0.4%
Connect Biopharma Holdings Ltd (CNTB)
Huang James — Director
Shares
150,000
Price
$2.48
Total Value
$371.61K
Shares Held After
13,310,000
% of Holdings
1.1%
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
15,152
Price
$12.98
Total Value
$196.67K
Shares Held After
74,848
% of Holdings
16.8%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$99.64
Total Value
$896.76K
Shares Held After
7,825
% of Holdings
53.5%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
250
Price
$223.32
Total Value
$55.83K
Shares Held After
4,267
% of Holdings
5.9%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
100
Price
$223.50
Total Value
$22.35K
Shares Held After
900
% of Holdings
11.1%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$222.30
Total Value
$44.46K
Shares Held After
800
% of Holdings
25.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$223.76
Total Value
$44.75K
Shares Held After
600
% of Holdings
33.3%
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,786
Price
$55.62
Total Value
$210.58K
Shares Held After
19,357
% of Holdings
16.4%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,129
Price
$2.57
Total Value
$5.47K
Shares Held After
9,970
% of Holdings
21.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,786
Price
$2.57
Total Value
$4.59K
Shares Held After
17,131
% of Holdings
10.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,829
Price
$2.57
Total Value
$4.70K
Shares Held After
9,840
% of Holdings
18.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,582
Price
$2.57
Total Value
$4.07K
Shares Held After
9,176
% of Holdings
17.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,292
Price
$2.57
Total Value
$5.89K
Shares Held After
10,758
% of Holdings
21.3%
Showing 51–100 of 3464 transactions (page 2 of 70)